That looks like the issue. Growth from $56M to $71m came from acquisitions, so organic not fantastic. Head count decline also suggests flat. Maybe another acquisition soon?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025